Enhanced Proinflammatory State and Autoimmune Activation: a Breakthrough to Understanding Chronic Diseases

Onat A., Can G.

CURRENT PHARMACEUTICAL DESIGN, cilt.20, sa.4, ss.575-584, 2014 (SCI-Expanded, Scopus) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 20 Sayı: 4
  • Basım Tarihi: 2014
  • Doi Numarası: 10.2174/138161282004140213145551
  • Dergi Adı: CURRENT PHARMACEUTICAL DESIGN
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.575-584
  • Anahtar Kelimeler: Autoimmune activation, coronary heart disease, type 2 diabetes, lipoprotein(a), metabolic syndrome, proinflammatory state, HIGH-DENSITY-LIPOPROTEIN, APOLIPOPROTEIN-A-I, CORONARY-HEART-DISEASE, METABOLIC SYNDROME, CARDIOVASCULAR-DISEASE, OXIDIZED PHOSPHOLIPIDS, INSULIN-RESISTANCE, DIABETES-MELLITUS, RISK-FACTORS, CHOLESTEROL LEVELS
  • İstanbul Üniversitesi-Cerrahpaşa Adresli: Hayır

Özet

Insight is provided herein into the novel mechanisms of cardiometabolic risk. Previous reports, including the epidemiological work of the Turkish Adult Risk Factor study, indicated that proinflammatory state and oxidative stress are crucial for evaluating cardiometabolic risk. Autoimmune pathways in the course of oxidative stress are major determinants of cardiorenal and metabolic risk. The latter encompasses metabolic syndrome, type 2 diabetes, coronary heart disease, and chronic kidney disease (CKD).